These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28718029)

  • 21. Thyroid-stimulating hormone concentration as an independent risk factor of venous thromboembolism regardless of thyroid function.
    Kovářová M; Koller T; Štvrtinová V; Payer J
    Endokrynol Pol; 2015; 66(6):474-9. PubMed ID: 26662645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis.
    Roetker NS; Armasu SM; Pankow JS; Lutsey PL; Tang W; Rosenberg MA; Palmer TM; MacLehose RF; Heckbert SR; Cushman M; de Andrade M; Folsom AR
    J Thromb Haemost; 2017 Jul; 15(7):1334-1343. PubMed ID: 28445597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Handgrip strength is not associated with risk of venous thromboembolism: a prospective cohort study.
    Kunutsor SK; Mäkikallio TH; Voutilainen A; Laukkanen JA
    Scand Cardiovasc J; 2020 Aug; 54(4):253-257. PubMed ID: 32281425
    [No Abstract]   [Full Text] [Related]  

  • 24. Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.
    Mahmoodi BK; Cushman M; Anne Næss I; Allison MA; Bos WJ; Brækkan SK; Cannegieter SC; Gansevoort RT; Gona PN; Hammerstrøm J; Hansen JB; Heckbert S; Holst AG; Lakoski SG; Lutsey PL; Manson JE; Martin LW; Matsushita K; Meijer K; Overvad K; Prescott E; Puurunen M; Rossouw JE; Sang Y; Severinsen MT; Ten Berg J; Folsom AR; Zakai NA
    Circulation; 2017 Jan; 135(1):7-16. PubMed ID: 27831499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of interleukin-6 and C-reactive protein genetic polymorphisms levels with venous thromboembolism.
    Mahemuti A; Abudureheman K; Aihemaiti X; Hu XM; Xia YN; Tang BP; Upur H
    Chin Med J (Engl); 2012 Nov; 125(22):3997-4002. PubMed ID: 23158132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of serum bilirubin levels in determining venous thromboembolism.
    Duman H; Özyurt S; Erdoğan T; Kara BY; Durakoğlugil ME
    J Vasc Surg Venous Lymphat Disord; 2019 Sep; 7(5):635-639. PubMed ID: 30922986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism.
    Hansen ES; Hindberg K; Latysheva N; Aukrust P; Ueland T; Hansen JB; Brækkan SK; Morelli VM;
    Blood; 2020 Oct; 136(16):1863-1870. PubMed ID: 32645137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study.
    Hald EM; Brækkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Brox J; Hansen JB
    Haematologica; 2011 Aug; 96(8):1189-94. PubMed ID: 21508123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study.
    Cugno M; Marzano AV; Bucciarelli P; Balice Y; Cianchini G; Quaglino P; Calzavara Pinton P; Caproni M; Alaibac M; De Simone C; Patrizi A; Cozzani E; Papini M; Tedeschi A; Berti E; Rosendaal FR;
    Thromb Haemost; 2016 Jan; 115(1):193-9. PubMed ID: 26245987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism.
    Bakirci EM; Topcu S; Kalkan K; Tanboga IH; Borekci A; Sevimli S; Acikel M
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):181-5. PubMed ID: 23814171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein N-linked homocysteine is associated with recurrence of venous thromboembolism.
    Szlauer A; Mielimonka A; Głowacki R; Borowczyk K; Stachniuk J; Undas A
    Thromb Res; 2015 Nov; 136(5):911-6. PubMed ID: 26371408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study.
    Holst AG; Jensen G; Prescott E
    Circulation; 2010 May; 121(17):1896-903. PubMed ID: 20404252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of incident venous thromboembolism on risk of arterial thrombotic diseases.
    Lind C; Flinterman LE; Enga KF; Severinsen MT; Kristensen SR; Braekkan SK; Mathiesen EB; Njølstad I; Cannegieter SC; Overvad K; Hansen JB
    Circulation; 2014 Feb; 129(8):855-63. PubMed ID: 24270266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of 25(OH)D are not associated with venous thromboembolism in the elderly population. A case-control study.
    Andro M; Delluc A; Moineau MP; Tromeur C; Gouillou M; Lacut K; Carré JL; Gentric A; Le Gal G
    Thromb Haemost; 2016 Jan; 115(1):169-75. PubMed ID: 26538494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time to Event Analysis for the Development of Venous Thromboembolism After Spinal Fusion ≥ 5 Levels.
    McClendon J; Smith TR; O'Shaughnessy BA; Sugrue PA; Thompson SE; Koski TR
    World Neurosurg; 2015 Sep; 84(3):826-33. PubMed ID: 25871780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abdominal obesity and the risk of venous thromboembolism among women: a potential role of interleukin-6.
    Matos MF; Lourenço DM; Orikaza CM; Gouveia CP; Morelli VM
    Metab Syndr Relat Disord; 2013 Feb; 11(1):29-34. PubMed ID: 23025692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of High-Dose Vitamin D3 on Soluble P-Selectin and hs-CRP Level in Patients With Venous Thromboembolism: A Randomized Clinical Trial.
    Gholami K; Talasaz AH; Entezari-Maleki T; Salarifar M; Hadjibabaie M; Javadi MR; Dousti S; Hamishehkar H; Maleki S
    Clin Appl Thromb Hemost; 2016 Jul; 22(5):483-9. PubMed ID: 25601896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline and long-term fibrinogen levels and risk of sudden cardiac death: A new prospective study and meta-analysis.
    Kunutsor SK; Kurl S; Zaccardi F; Laukkanen JA
    Atherosclerosis; 2016 Feb; 245():171-80. PubMed ID: 26724527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble urokinase plasminogen activator receptor and incidence of venous thromboembolism.
    Engström G; Zöller B; Svensson PJ; Melander O; Persson M
    Thromb Haemost; 2016 Mar; 115(3):657-62. PubMed ID: 26466866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.